Pulmonary Hypertension and Chronic Lung Disease: Diagnosis and Management
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Respiratory Medicine".
Deadline for manuscript submissions: 20 July 2026 | Viewed by 654
Special Issue Editors
Interests: COPD; cardiovascular risk; epidemiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pulmonary hypertension (PH) is a frequent and underestimated complication among patients with chronic lung diseases, particularly those with chronic obstructive pulmonary disease (COPD). The interplay between pulmonary vascular remodeling, hypoxia, inflammation, and systemic comorbidities leads to significant morbidity and mortality. This Special Issue aims to gather original research, reviews, and clinical insights that advance the understanding of epidemiology, pathophysiology, diagnosis, and treatment of PH in chronic lung disease.
We are particularly interested in studies focusing on real-world data, population-based analyses, and epidemiological approaches to identify predictors of disease progression, exacerbations, and outcomes. Topics may include the interaction between cardiovascular and metabolic comorbidities (such as diabetes or obesity), biomarkers of systemic inflammation, new therapeutic strategies, and the role of multidisciplinary management in improving patient prognosis. Our goal is to promote translational research and bridge the gap between clinical practice and emerging scientific evidence.
Dr. Josep Montserrat-Capdevila
Dr. Emmanuel E. Egom
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary hypertension
- chronic obstructive pulmonary disease (COPD)
- chronic lung disease
- epidemiology
- exacerbations
- comorbidities
- risk factors
- diabetes
- systemic inflammation
- real-world data
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
